The Effects of Cyclin D1 and Bcl-2 Expressıon on Aggressive Behavior in Basal Cell and Basosquamous Carcinoma

Overview

Journal Iran J Pathol

Date 2015 Sep 10

PMID 26351483

Citations 9

Authors

Oya N Sivrikoz

Gulsen Kandiloglu

Affiliations

Soon will be listed here.

Abstract

Background And Objective: Clinical behavior of basal cell carcinoma (BCC) is known to be different according to histological growth pattern and basosquamous cell carcinomas (BSC) are known with their aggressive behavior and metastatic capacity. In this study, we evaluated bcl-2 and cyclin D1 expressions in BCC and BSC cases comparatively, to explore their predictive value on the aggressive behavior of these tumors.

Methods: One hundred tumors belong to 92 patients diagnosed as basal cell carcinoma and basosquamous carcinoma were studied. Basal cell carcinomas were classified as aggressive and non-aggressive types according to growth pattern. Number of Cyclin D1 and bcl-2 positive cells in immunohistochemically stained serial sections were scored as low (0-1 +) and high (2 and 3+) in all tumors.

Results: A statistically significant difference was found between non-aggressive (nodular type) and aggressive types (micronodular, infiltrative types and BSC) for these markers ( P <0.005). Cyclin D1 was higher in the aggressive group, while bcl-2 was lower in the aggressive group compared to the non-aggressive group.

Conclusion: Higher Cyclin D1 and lower bcl-2 scores was correlated with aggressive tumor types and these results could be used as markers to predict aggressive behavior in BCC and BSCs.

Citing Articles

Association of the expression of Bcl-2 and Ki-67 prognostic markers and apoptotic index with biological behaviour in aggressive and non-aggressive non-melanoma eyelid skin cancer.

Pridavkova Z, Plank L, Ziak P, Halicka J, Benca-Kapitanova K, Vida R Postepy Dermatol Alergol. 2024; 41(5):456-462.

PMID: 39606595 PMC: 11589630. DOI: 10.5114/ada.2024.144402.

Cyclin D1 expression in penile cancer.

Duarte W, Pinho J, Melo S, Duarte D, Carmo J, Khayat A Oncotarget. 2024; 15:302-311.

PMID: 38742684 PMC: 11092173. DOI: 10.18632/oncotarget.28584.

The Importance of Basal Cell Carcinoma Risk Stratification and Potential Future Pathways.

Paul S, Knight A JMIR Dermatol. 2023; 6:e50309.

PMID: 37902813 PMC: 10644189. DOI: 10.2196/50309.

Prediction of Diagnostic Gene Biomarkers Associated with Immune Infiltration for Basal Cell Carcinoma.

Xie D, Chen X, Wu H, Ning D, Cao X, Wan C Clin Cosmet Investig Dermatol. 2022; 15:2657-2673.

PMID: 36536759 PMC: 9758983. DOI: 10.2147/CCID.S390770.

Immunoexpression of Bmi-1, CK15, Bcl-2 in different types of basal cell carcinomas.

Iljin A, Stasikowska-Kanicka O, Zielinski T, Bakiewicz A, Sporny S, Wozniak-Roszkowska E Postepy Dermatol Alergol. 2022; 39(5):980-985.

PMID: 36457690 PMC: 9704448. DOI: 10.5114/ada.2022.120888.

References

Bozdogan O, Erkek E, Atasoy P, Kocak M, Birol A, Caydere M . Bcl-2-related proteins, alpha-smooth muscle actin and amyloid deposits in aggressive and non-aggressive basal cell carcinomas. Acta Derm Venereol. 2003; 82(6):423-7. DOI: 10.1080/000155502762064548. View

Saldanha G, Fletcher A, Slater D . Basal cell carcinoma: a dermatopathological and molecular biological update. Br J Dermatol. 2003; 148(2):195-202. DOI: 10.1046/j.1365-2133.2003.05151.x. View

LOPES DE FARIA J, Nunes P . Basosquamous cell carcinoma of the skin with metastases. Histopathology. 1988; 12(1):85-94. DOI: 10.1111/j.1365-2559.1988.tb01919.x. View

El-Bahrawy M, El-Masry N, Alison M, Poulsom R, Fallowfield M . Expression of beta-catenin in basal cell carcinoma. Br J Dermatol. 2003; 148(5):964-70. DOI: 10.1046/j.1365-2133.2003.05240.x. View

Ramdial P, Madaree A, Reddy R, Chetty R . bcl-2 protein expression in aggressive and non-aggressive basal cell carcinomas. J Cutan Pathol. 2000; 27(6):283-91. DOI: 10.1034/j.1600-0560.2000.027006283.x. View

Kricker A, Armstrong B, English D, Heenan P . A dose-response curve for sun exposure and basal cell carcinoma. Int J Cancer. 1995; 60(4):482-8. DOI: 10.1002/ijc.2910600410. View

Sexton M, Jones D, Maloney M . Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. J Am Acad Dermatol. 1990; 23(6 Pt 1):1118-26. DOI: 10.1016/0190-9622(90)70344-h. View

Beer T, Shepherd P, Theaker J . Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin. Histopathology. 2000; 37(3):218-23. DOI: 10.1046/j.1365-2559.2000.00999.x. View

Randle H . Basal cell carcinoma. Identification and treatment of the high-risk patient. Dermatol Surg. 1996; 22(3):255-61. DOI: 10.1111/j.1524-4725.1996.tb00316.x. View

10.

Borel D . Cutaneous basosquamous carcinoma. Review of the literature and report of 35 cases. Arch Pathol. 1973; 95(5):293-7. View

11.

Ibrahim Z, Narihan M, Ojep D, Soosay A, Pan K . Cyclin D1 expression in acral melanoma: a case control study in Sarawak. Malays J Pathol. 2013; 34(2):89-95. View

12.

Khan Z . Basal cell carcinoma with thickened basement membrane. Am J Dermatopathol. 1999; 21(1):111-2. DOI: 10.1097/00000372-199902000-00092. View

13.

Bowman P, Ratz J, Knoepp T, Barnes C, Finley E . Basosquamous carcinoma. Dermatol Surg. 2003; 29(8):830-2; discussion 833. DOI: 10.1046/j.1524-4725.2003.29217.x. View

14.

Silverman M, Kopf A, Grin C, Bart R, Levenstein M . Recurrence rates of treated basal cell carcinomas. Part 1: Overview. J Dermatol Surg Oncol. 1991; 17(9):713-8. DOI: 10.1111/j.1524-4725.1991.tb03424.x. View

15.

Martin 2nd R, Edwards M, Cawte T, Sewell C, McMasters K . Basosquamous carcinoma: analysis of prognostic factors influencing recurrence. Cancer. 2000; 88(6):1365-9. DOI: 10.1002/(sici)1097-0142(20000315)88:6<1365::aid-cncr13>3.0.co;2-y. View

16.

DE FARIA J . Basal cell carcinoma of the skin with areas of squamous cell carcinoma: a basosquamous cell carcinoma?. J Clin Pathol. 1985; 38(11):1273-7. PMC: 499426. DOI: 10.1136/jcp.38.11.1273. View

17.

Staibano S, Lo Muzio L, Pannone G, Mezza E, Argenziano G, Vetrani A . DNA ploidy and cyclin D1 expression in basal cell carcinoma of the head and neck. Am J Clin Pathol. 2001; 115(6):805-13. DOI: 10.1309/GGE7-WL7J-VRWD-R4VG. View

18.

Lock-Andersen J, Drzewiecki K, Wulf H . Eye and hair colour, skin type and constitutive skin pigmentation as risk factors for basal cell carcinoma and cutaneous malignant melanoma. A Danish case-control study. Acta Derm Venereol. 1999; 79(1):74-80. DOI: 10.1080/000155599750011778. View

19.

Delehedde M, Cho S, Sarkiss M, Brisbay S, Davies M, El-Naggar A . Altered expression of bcl-2 family member proteins in nonmelanoma skin cancer. Cancer. 1999; 85(7):1514-22. View

20.

Mateoiu C, Pirici A, Bogdan F . Immunohistochemical nuclear staining for p53, PCNA, Ki-67 and bcl-2 in different histologic variants of basal cell carcinoma. Rom J Morphol Embryol. 2011; 52(1 Suppl):315-9. View